Robert Busch, MD

An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.

Takeaways of the REDUCE-IT trial of icosapent ethyl as treatment for dyslipidemia and hypertriglyceridemia.

The role of ezetimibe and PCSK9 inhibitors as treatment for patients who are statin intolerant or require add-on therapy to help reduce cholesterol levels.

What to know about the efficacy of statin therapies used as cholesterol-lowering therapy.

The standard of care for managing high cholesterol levels.

The value of interdisciplinary research and multidisciplinary care of patients at high risk for cardiovascular events.